Recent Publications by BioReliance Corporation: |
Further evaluation of a flow cytometric in vitro micronucleus assay in CHO-K1 cells: a reliable platform that detects micronuclei and discriminates apoptotic bodies.
The in vitro micronucleus (MN) assay is widely used to assess genotoxic... | 22nd October, 2009
| Department of Genetic Toxicology, BioReliance Corporation, 14920 Broschart
| Mutagenesis. 2009 Oct 20.
DOI Direct Link |
Comparison of manufacturing techniques for adenovirus production.
We have compared three different production methods, which may be suitable... | 13th November, 2008
| BioReliance Corporation, 9900 Blackwell Road, Rockville, Maryland, 20850,
| Cytotechnology. 1999 Jul;30(1-3):169-72.
DOI Direct Link |
Syrian hamster embryo (SHE) cell transformation assay with conditioned media (without X-ray irradiated feeder layer) using 2,4-diaminotoluene, 2,6-diaminotoluene and chloral hydrate.
The Syrian hamster embryo (SHE) cell transformation assay has... | 10th September, 2008
| Genetic Toxicology Department, BioReliance, Rockville, MD 20850, United
| Mutat Res. 2008 Jul 31;654(2):108-13. Epub 2008 May 18.
DOI Direct Link |
Detection of adventitious viruses in biologicals--a rare occurrence.
Adventitious virus assays are performed as part of raw materials testing,... | 4th May, 2006
| Adventitious Virus Testing, BioReliance, Invitrogen Bioservices,
| Dev Biol (Basel). 2006;123:153-64; discussion 183-97.
|
Scope and practicality of in vivo testing for adventitious agents.
An overview of the in vivo assays currently performed to test for the... | 4th May, 2006
| BioReliance Corporation, Invitrogen Bioservices, Rockville, MD 20850, USA.
| Dev Biol (Basel). 2006;123:147-52; discussion 183-97.
|
Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay.
Product safety testing for retroviruses can be achieved by a panel of... | 4th May, 2006
| Biologics Testing, BioReliance, Invitrogen Bioservices, Rockville, MD
| Dev Biol (Basel). 2006;123:91-7; discussion 119-32.
|
Chromium picolinate does not produce chromosome damage in CHO cells.
Chromium picolinate (CrPic, Chromax) is a dietary supplement that has been... | 21st December, 2005
| BioReliance Corporation, 14920 Broschart Road, Rockville, MD 20850, USA.
| Mutat Res. 2005 Nov 10;587(1-2):140-6. Epub 2005 Oct 10.
DOI Direct Link |
Animal virus contaminants of biotechnology products.
Chromium picolinate (CrPic, Chromax) is a dietary supplement that has been... | 19th April, 2005
| BioReliance
| Dev Biol (Basel). 2004;118:155-63.
|
PDA Virus Filter Task Force update.
The PDA Virus Filter Task Force has made significant progress in producing... | 19th April, 2005
| BioReliance,
| Dev Biol (Basel). 2004;118:129-31.
|
Developing new infectivity assays.
The PDA Virus Filter Task Force has made significant progress in producing... | 19th April, 2005
| BioReliance, West of Scotland Science Park, Glasgow, UK.
| Dev Biol (Basel). 2004;118:47-53.
|
Regulatory and microbiological safety issues surrounding cell and tissue-engineering products.
Cell therapies and tissue-engineered products that contain living cells... | 11th February, 2005
| BioReliance Corporation, Todd Campus, West of Scotland Science Park,
| Biotechnol Appl Biochem. 2004 Aug;40(Pt 1):35-9.
DOI Direct Link |
Current issues in validation of chromatography.
Chromatography has now been used successfully for more than 20 years to... | 1st May, 2004
| BioReliance
| Dev Biol (Basel). 2003;113:61-4.
|
Biosafety and product release testing issues relevant to replication-competent oncolytic viruses.
Replication competent oncolytic viruses, like other biological products,... | 14th June, 2003
| BioReliance,
| Cancer Gene Ther. 2002 Dec;9(12):1056-61.
DOI Direct Link |
Recommended approaches for the evaluation of testicular and epididymal toxicity.
Replication competent oncolytic viruses, like other biological products,... | 13th March, 2003
| BioReliance Corporation, Rockville, Maryland 20850, USA.
| Toxicol Pathol. 2002 Jul-Aug;30(4):507-20.
|
Validation of biopharmaceutical purification processes for virus clearance evaluation.
Any biopharmaceutical product that has involved the use of animal-derived... | 27th December, 2002
| BioReliance Corp, Biosafety Testing Division, Rockville, MD 20850, USA.
| Mol Biotechnol. 2002 May;21(1):57-83.
DOI Direct Link |
